lions gate entertainment cor
(LGF:New York)

Executive Profile*

Background*

Dr. Mark H. Rachesky, M.D., is a Co-Founder, President, and Investment Chief at MHR Fund Management LLC. Dr. Rachesky co-founded MHR Fund Management in 1996. Dr. Rachesky served as Managing Director at Icahn Holding Corp., from February 1, 1990 to June 11, 1996. From June 1987 to January 1990, he served at an affiliate of the Robert M. Bass Group, where Dr. Rachesky was involved in financing and investment activity. He has been the Chairman of Leap Wireless International ... Inc., since August 2004. He serves as Chairman of Lions Gate Entertainment Corp. He has been Chairman of the Board at Telesat Canada since October 2007. He has been Chairman of Telesat Holdings Inc., since October 31, 2007. He has been Non-Executive Chairman of the Board of Directors of Loral at Space Systems/Loral, Inc., since March 1, 2006. Dr. Rachesky has been the Non Executive Chairman of Loral Space & Communications, Inc. since March 1, 2006 and has been its Director since November 2005. He serves as Chairman of the Board at Cricket Communications, Inc. and has been its Director since August 2004. He served as the Co-Chairman of Lions Gate Entertainment Corp and has been its Director since September 2009. He has been a Director of Neose Technologies Inc., since 1999 and Culligan Water Technologies Inc., since September 1995. He has been a Director of Loral at Space Systems/Loral, Inc., since March 1, 2006. He has been a Director of Space Systems/Loral, Inc., since November 2005. He has been a Director of NationsHealth Inc., since October 20, 2005. He has been a Director at Navistar International Corporation since October 8, 2012. He serves as a Director of SS/L Holdings, Inc. He has been a Director of Emisphere Technologies Inc., since September 2005. Dr. Rachesky served as a Director of Keryx Biopharmaceuticals Inc. He served as a Director of Samsonite Corp., from 1993 to April 21, 2003. He served as a Director of Millstream Acquisition Corporation since October 2005. He served as a Director of Culligan International Company since September 1995. Dr. Rachesky was a Director of Novadel Pharma Inc., since June 2003. Dr. Rachesky holds an M.D. degree from the Stanford University School of Medicine, an M.B.A. degree from the Stanford University School of Business, and a B.S. degree in Molecular Aspects of Cancer from the University of Pennsylvania.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
LGF:US	$28.06 USD	+0.40

COMPETITOR COMPENSATION